HIV-Prä-Expositionsprophylaxe in der Schweiz
M. Weber(University of Zurich), Benjamin Hampel(University of Zurich), Dunja Nicca(University of Basel), Vanessa Christinet(University of Zurich), Matthias Cavassini(University of Zurich), Andreas F. Lehner(University of Zurich), Emanuelle Boffi El Amari(University of Zurich), Matthias Reinacher(University of Zurich), Raphaël Bize(Centre universitaire de médecine générale et santé publique, Lausanne), Alexandra Calmy(University Hospital of Geneva), Roger D. Kouyos(University of Zurich), Axel J. Schmidt(University of Zurich), Jan Fehr(University Hospital of Zurich), Carsten Depmeier(Praxis), Nicola Low(University of Washington), Pietro Vernazza(University of Zurich), Dominique L. Braun(University of Zurich), Christoph Hauser(University of Bern), Marcel Stckle(University of Zurich), J�rg B�ni(University of Zurich), Manuela Rasi(University of Zurich), Enos Bernasconi(University of Geneva), David Haerry(The Geneva Association), Severin Luchli(University of Zurich)
Cited by 0
Related Papers
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis
|PLoS Medicine|2020|1.1k
Mpox in people with advanced HIV infection: a global case series
|The Lancet|2023|482
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
|British Journal of Cancer|2010|301
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population
|Annals of Internal Medicine|2022|189